Safety and efficacy of thoracic radiotherapy combined with chemo-immunotherapy in patients with extensive-stage small cell lung cancer: a multicenter retrospective analysis

BACKGROUND: Immunotherapy has greatly increased the survival time of patients with extensive-stage small cell lung cancer (ES-SCLC), and is now a standard first-line treatment for these patients. Increasing evidence suggests a possible synergistic effect between immunotherapy and radiotherapy, yet t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Zijing, Gu, Xiaoling, Xie, Jingyuan, Cheng, Di, Chen, Jiayan, Cheng, Jing, Ye, Jinjun, Lv, Tangfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654438/
https://www.ncbi.nlm.nih.gov/pubmed/38025813
http://dx.doi.org/10.21037/tlcr-23-294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654438/
https://www.ncbi.nlm.nih.gov/pubmed/38025813
http://dx.doi.org/10.21037/tlcr-23-294

Ejemplares similares